PR Newswire
15 Jun 2022, 23 GMT+10
The company obtained a European Access Permit for in-vitro diagnostics devices (IVDD) authorized by the Netherlands CIBG of Ministry of Health, Welfare and Sport.
GUANGZHOU, China, June 15, 2022 /PRNewswire/ -- PulmoSeekTM Lung Cancer Early Detection Assay, the non-invasive blood-based cfDNA methylation detection product developed by AnchorDx for the early diagnosis of lung cancer, recently completed the procedure for EU IVDD CE Marking, and obtained IVD reagents licensing signed and issued by the CIBG of Ministry of Health, Welfare and Sport in the Netherlands. The license number is NL-CA002-2022-71591.
PulmoSeekTM is applicable for the benign and malignant diagnosis of people with 5-30mm pulmonary nodules. In the earlier stage of prospective clinical studies at 14 centers, the product's excellent performance was well verified in the following:
According to GLOBOCAN 2020 data released by the International Agency for Research on Cancer (IARC), lung cancer is the leading cause of cancer deaths (18%) with more than 2.2 million new cases and 1.8 million deaths annually worldwide. As a screening technology for lung cancer, LDCT has been widely recognized by domestic and international clinical guidelines, but the precise management of patients with pulmonary nodules after LDCT screening has also become an urgent clinical problem to be solved.
PulmoSeekTM Lung Cancer Early Detection Assay can achieve early diagnosis and treatment of lung cancer through accurate diagnosis of patients with benign and malignant pulmonary nodules. Currently, several of AnchorDx's products have obtained relevant IVD-related qualifications from US FDA and European Medicines Agency (EMA). PulmoSeek's access permit for the EU market will further promote this innovative precision medical product to benefit more patients with pulmonary nodules around the world forthwith.
About AnchorDx
AnchorDx is a world-leading developer of cancer screening and early detection solutions based on methylation NGS technology. AnchorDx strives to revolutionize single/multi/pan-cancer early screening, detection technologies, and products. The current product pipeline encompasses more than 70% of all cancers.
CONTACT : PR@anchordx.com
SOURCE Guangzhou AnchorDx Co., LTD
Get a daily dose of Philippine Times news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Philippine Times.
More InformationMOSCOW, Russia: The UK newspaper, the Telegraph, has been blocked in Russia, following a request from the Russian prosecutor-general.The TASS ...
LAHORE, Pakistan - An Airbus 320 carrying 171 passengers narrowly avoided an accident at Allama Iqbal International Airport, Pakistan's second-largest ...
WASHINGTON, DC - U.S. President Joe Biden on Friday vowed to "do all in my power" to protect a woman's ...
YANGON, Myanmar - According to military-run media, a junta delegation discussed nuclear technology collaboration with a Russian state-owned atomic energy ...
DHAKA, Bangladesh - The United States Agency for International Development (USAID) is providing more than Tk2.3 crore in emergency funding ...
PHNOM PENH, Cambodia: Cambodian villagers on the Mekong River have caught a stingray fish weighing 661 pounds, which is the ...
WASHINGTON D.C.: Raytheon Technologies and Northrop Grumman have won U.S. contracts to develop missiles to intercept hypersonic weapons.The decision means ...
NEW YORK, New York - Stocks in Asia fell sharply on Wednesday following large falls on Wall Street blamed on ...
NEW DELHI, India: Reserve Bank of India (RBI) deputy governor Michael Patra says India's retail inflation is likely to breach ...
WASHINGTON D.C.: Despite weather and staffing issues resulting in travel disruptions, last week the U.S. Transportation Security Administration (TSA) screened ...
NEW YORK, New York - Disappointing economic data put an end to Wall Street's recent rally Tuesday, with all indices ...
LONDON, England: According to a report in the UK's Guardian newspaper, a government advisory agency, the National Health Service Pay ...